Protective studies were conducted with mice by using recombinantly produced antigens, polyacrylamide gel electrophoresis-fractionated antigens, and a monoclonal antibody specific to the 28-kDa antigen of Ehrlichia risticii. Analysis of E. risticii-infected cell culture used as the challenge inoculum indicated an inverse relationship between the progression of cell culture infection and the infective capability of E. risticii for mice. A recombinant 44-kDa antigen was found to protect mice considerably against challenge infection, while the monoclonal antibody and fractionated antigens were not protective. A potentiation of protection was observed when the recombinant 44-kDa antigen was combined with the recombinant 70-kDa antigen and used for mouse immunization.
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Potomac horse fever, which affects horses of all ages, is caused by Ehrlichia risticii (5, 10, 20) . This pathogen is another example of obligate intracellular parasitism, and its significance is intensified by the ability of E. risticii to invade and multiply inside one of the main effector cells of the immune system, the macrophages (11) .
The study of E. risticii so far has resulted in the identification of component antigens (9) and the development of diagnostic assays for serum antibodies (7, 17, 24) and genomic DNA (3, 28) . The next phase of the study concerns protection against the disease. The large-scale growth of E. risticii is expensive, and vaccination with the whole organism may not be readily acceptable in nonendemic areas. Furthermore, the effect of long-term in vitro growth on the protective capability of E. risticii is not known. Studies are needed to identify antigenically defined immunoprotective components with potential for the development of a subunit vaccine and to facilitate further studies on the molecular pathogenesis of E. risticii.
As an intracellular parasite, E. risticii elicits intense humoral and cellular immune responses to an infection (4, 16, 17, 19) . In spite of the efficiency of tetracycline (31) in treating clinical cases of rickettsial infection (32), the immune response is still considered necessary for the clearance of organisms in an rickettsial infection (25, 26) . Protective immunity to Potomac horse fever in horses following initial infection with E. risticii (16) or E. sennetsu (21) and in mice infected or immunized with E. risticii (8) has been demonstrated. Recently, in a mouse study, the protection against E. risticii by passive transfer of antibodies was demonstrated (12) . Also, protection to various degrees has been demonstrated with the use of a commercially available vaccine to Potomac horse fever (22) . In Potomac horse fever, the antibodies to several specific component antigens have been shown to appear at 4 to 5 weeks after infection (4), at which time they are refractile to challenge infection (6), suggesting that one or few of these component antigens might be t Present address: Department of Pathology, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15261. involved in the protective immunity. The presence of immunodominant protective antigens in other rickettsiae has been demonstrated by using monoclonal antibodies (1, 2, 13) and recombinant antigens (14, 29) .
We reported earlier the cloning of 44-, 55-, and 70-kDa antigen genes of E. risticii in lambda gtll and a low protective capability of the affinity-purified 55-kDa recombinant antigen in mice (8) . The 55-kDa recombinant antigen is a nonfusion full protein, whereas the 70-and 44-kDa recombinant antigens are fusion proteins representing about 50 and 73% of the native protein counterparts, respectively. In this paper we report the considerable protective capability of the recombinant 44-kDa antigen and the results of other methods used to evaluate the protective capabilities of different antigens. Also we report the relationship between the progression of E. risticii infection in cell culture and mice infectivity.
MATERIALS AND METHODS
E. risticii and E. risticii-infected cell culture inoculum for infection of mice. E. risticii isolated in our laboratory (5) was propagated in human histiocyte (HH) cells (ATCC U-937) in RPMI 1640 medium. For continuous cultures, to 20 ml of E. risticii-infected HH cells (more than 90%) 20 million naive HH cells in logarithmic phase were added and adsorbed for 1 h at 37°C. Eighty milliliters of prewarmed media was then added, and incubation was continued at 37°C in the presence of 5% CO2 (7) . The cell culture-propagated E. risticii (HH-ER) was standardized as an inoculum for mice infection. For this, the growth of E. risticii in HH cell culture was monitored for viability by trypan blue exclusion and for percent infection by acridine orange staining (5) and by immunofluorescence assay with a monoclonal antibody (HybI) specific for the 28-kDa antigen (23 Recombinant antigens for immunization of mice were prepared from Escherichia coli Y1089 lysogens corresponding to the 44-, 55-, and 70-kDa antigens encoded by lambda gtll clones (8) . The lysogens were grown to an optical density at 600 nm of 0.5 at 32°C and the temperature was shifted rapidly to 42°C and incubated at that temperature for 20 minutes. Isopropylthiogalactoside (IPTG) was added to 10 mM, and incubation was continued at 37°C for 1 h. After being pelleted at 3,000 x g and resuspended to 1/50 volume in TEP buffer (100 mM Tris, pH 7.6, 10 mM EDTA, 0.2 mM phenylmethylsulfonyl fluoride, 0.2 mM iodoacetamide), the cells were freeze-thawed three times in liquid nitrogen and sonicated three times for 30 s. Following centrifugation at 8,000 x g for 10 min, the supernatants were collected and evaluated for the presence of the E. risticii antigen by Western blotting and were then stored frozen at -70°C.
Immunization of mice. Female Sprague-Dawley CF-1 mice (Harlan Sprague Dawley, Inc., Indianapolis, Ind.) used were about 5 weeks of age at the start of immunization. For immunization of mice with SDS-PAGE-fractionated antigens, four mice in each group were immunized by the intraperitoneal injection of 50 ,ug of protein mixed with Freund's incomplete adjuvant. This adjuvant was used since the polyacrylamide pieces carried over were presumed to possess adjuvant properties. The second and third inoculations, administered 14 and 31 days later, respectively, contained 25 pug of the protein alone. The control groups comprised unimmunized mice, mice immunized with an extract processed as described above from a mock electrophoresis, mice immunized with a combination of all the fractions, and mice previously immunized with the whole E. risticii organism. These mice were challenge infected 41 days postimmunization (p.i.), and tail-bled serum samples were collected on days 21, 38, and 67 p.i.
Passive immunization of mice with the monoclonal antibody HybI (23) was scored as four; and death was scored as five. Clinical signs judged to fall between any two stages were scored as fractions of the corresponding scores. Blind scores were averaged for each group and analyzed. RESULTS E. risticii infectivity. The kinetics of growth of E. risticii in HH cells are presented in Fig. 1 . The immunofluorescence assay with monoclonal antibody HybI was consistently superior to acridine orange staining in detecting the E. risticii infection. However, because of the simplicity of the acridine orange staining, it was used to demarcate the different groups of infectivity. A good agreement in the relationship between the viability of HH cells and the progression of infection could also be observed. This evaluation provides a semiquantitative profile of the growth characteristics of E. risticii in cell culture. Under the conditions standardized, cultures on days 4, 5, and 6 of infection were found to contain approximately 25, 50 , and 75% infected cells, respectively.
Since our earlier observations (unpublished) had indicated a low pathogenicity of cell culture-propagated E. risticii in mice when a high percentage of infected cells were present, it was thought that the viability of E. risticii infected cells might be important. Hence, a comparative analysis of the mouse pathogenicity of E. risticii at different stages of the infective process in cell culture was undertaken. The results (Fig. 2) indicated that the pathogenicity in mice was drastically reduced in very short periods of the cell culture infective process. The 25% infective HH-ER was highly pathogenic for mice, and the administration of 107 cells resulted in the death of all mice in the group. The initial peak of sickness in the first 3 days seems to be the result of an apparent general toxicity of the inoculum, as can be noticed more prominently in Fig. 2F . Although inoculation of 107 cells generally induced pronounced sickness, a general trend of decreasing pathogenicity with the progression of infectivity could be observed from the results. These data helped to standardize the E. risticii inoculum more efficiently.
Antibody response in mice to PAGE-fractionated and recombinant E. risticii antigens. Mice immunized with the 110-, 70-, and 51-and 44-kDa PAGE-fractionated antigen groups produced high ELISA antibody titers (Fig. 3a) . The Western blot analysis of these sera (Fig. 3b) specificity of the response in all the groups, and their reactivity with 70-, 51-, 44-, and 28-kDa antigens was highly pronounced.
Antibody response of the mice immunized with 44-and 70-kDa recombinant antigens and the antigen combinations detected by ELISA and immunoblot is presented in Fig. 4 . The antisera from mice immunized with the 44-kDa recombinant antigen exhibited high ELISA titers and an intense Western blot reactivity with the homologous antigen of E. risticii. This immunoblot reactivity was matched in the 41-day-p.i. sera from the 44-plus 70-kDa antigen group, while it was not observed for 30-or 41-day-p.i. sera from the 44-plus 55-plus 70-kDa antigen group. The reactivity with the specific antigens appeared to intensify following challenge infection in almost all the groups. Since crude E. coli extracts were used as inocula for the recombinant antigens, purified E. risticii organisms had to be used as the ELISA antigens for the evaluation of specific antibody response.
The use of whole E. coli cell extracts for immunization with recombinant antigens resulted in the production of antibodies to many E. risticii proteins (Fig. 4b) Fig. 5 . The protection observed in mice immunized with the 44-kDa antigen alone seemed to be potentiated by combining this antigen with 70-kDa recombinant antigen. Surprisingly, the intensity of sickness in mice immunized with the BNN97 cell control was reduced compared with that in the unimmunized mice, which followed the pattern observed in the infectivity titration studies (Fig.  2) . The mice immunized with E. risticii were completely protected from any signs of sickness. (24) . However, this monoclonal antibody did not protect the mice from challenge infection. The lack of protection with HybI could be an indication that the epitope recognized by HybI is not involved in proteCtion directly or indirectly as a consequence of steric modification ensuing binding of the monoclonal antibody. An attempt was then made to study the protective response to PAGE-separated whole proteins of E. risticii. Significant antibody responses were revealed by ELISA and substantiated by specific Western blot reactivity. However, the lack of protection observed here could be the result of an irreversible denaturation of SDS-sensitive epitopes. It is interesting that the presence of antibodies to SDS-denatured proteins of E. risticii in the preinfective sera of horses and their subsequent susceptibility to E. risticii have been observed (4) .
DISCUSSION
Production of recombinant E. risticii proteins will provide pure proteins in a relatively native state. In the earlier evaluation of the protective capability of 55-kDa recombinant antigen, we had utilized affinity purified protein (8) . Since the affinity purification will also involve some form of a denaturation step, the experiments described in this paper were conducted by utilizing crude lysates of the recombinant products. Efficiency of specific immunization was demonstrated by ELISA and Western blot reactivities. However, the observed reactivity of these mouse sera with several E. risticii proteins could be the result of recognition of proteins homologous between E. coli and E. risticii. Such homology in the heat shock family of proteins has been noted in other rickettsiae (27, 30) , and a similar phenomenon is highly probable because of the growth of E. coli at high temperatures.
Significant protection from clinical signs observed in mice immunized with the recombinant 44-kDa antigen and its combinations is encouraging. In fact, a potentiation of the protective response was observed in mice immunized with combinations of recombinant antigens. Further, our result is substantiated by the protective role for the 44-kDa antigen hypothesized by Rikihisa and coworkers (21) . They based this finding on the reactivity of E. sennetsu-immunized horse sera with the 44-kDa antigen of E. risticii concomitant with protection from E. risticii challenge infection. In view of the extensive cross-reactivity between these two species in almost all the antigens (22a), our results provide evidence of the protective capability of the 44-kDa antigen. The lack of complete susceptibility of mice immunized with BNN97 might be due to a general heightened immune status. The enhanced release of several lymphokines under such circumstances and the reported inhibitory effect of gamma interferon on rickettsial intracellular parasites (15) might have compromised the infectivity of E. risticii.
In view of an earlier observation that E. risticii-infected cell culture was less effective in establishing infection in mice than were infected horse blood leukocytes (6, 19) , we hypothesized the presence of a relationship between the progression of infection in cell culture and the mouse infectivity. Our results clearly demonstrate the presence of an inverse relationship between these two variables. It is possible that a visible indication of the saturation of host cell with the progeny of parasites, accompanied by cell death, might be a reflection of the loss of viability of these organisms in general.
We have demonstrated the protective nature of the 44-kDa recombinant protein against E. risticii infection in mice. Future studies will be aimed at cloning the full gene for the 44-kDa antigen and determining the humoral and cell-mediated immune responses in elucidating the immunoprotectivity of this antigen.
